1 Baskin et al.. Lancet 2009;374:159–69.
2 Center for Disease Control; https://www.cdc.gov/vitalsigns/protect-patients/infographic.html
3 Hadaway, Lynn “Heparin Locking for Central Venous Catheters; JAVA, Volume 11 No 4 2006″
4 MISSING REFERENCE
5 Liu et. al, mSphere, November/December 2018 Volume 3 Issue 6 e00525-18, 2018
6 Hill et al. 2020; manuscript pending
7 https://www.jointcommission.org/resources/patient-safety-topics/infection-prevention-and-control/central-line-associated-bloodstream-infections-toolkit-and-monograph/
8 Moureau N, Poole S, Murdock MA, et al. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol 2002; 13(10):1009–16.
9 Hill et al, 2020; manuscript pending
10 Liu et. al, mSphere, November/December 2018 Volume 3 Issue 6 e00525-18, 2018
11 Quirt et al, 2020; manuscript pending
12 https://pubmed.ncbi.nlm.nih.gov/29042186/#:~:text=Bacterial%20biofilms%20are%20usually%20pathogenic,are%20associated%20with%20biofilm%20formation
13 https://theconversation.com/drug-resistant-superbugs-a-global-threat-intensified-by-the-fight-against-coronavirus-135790